Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, and Urinary and Genital Oncology Studies.
Prostate Cancer, Version 3.2024
Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer
Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
SPOP mutation induces DNA methylation via stabilizing GLP/G9a
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
Genetic factors associated with prostate cancer conversion from active surveillance to treatment
MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression
Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate
Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of <sup>68</sup> Ga-PSMA and <sup>11</sup> C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches
Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer
Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target